Fabry's disease surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:


{{Fabry's disease}}
{{Fabry's disease}}
 
==Overview==
== Surgery ==
== Surgery ==



Revision as of 18:09, 9 May 2022


Fabry's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fabry's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fabry's disease surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fabry's disease surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fabry's disease surgery

CDC on Fabry's disease surgery

Fabry's disease surgery in the news

Blogs on Fabry's disease surgery

Directions to Hospitals Treating Fabry's disease

Risk calculators and risk factors for Fabry's disease surgery

Overview

Surgery

References

  1. Mignani R, Feriozzi S, Pisani A, Cioni A, Comotti C, Cossu M; et al. (2008). "Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy". Nephrol Dial Transplant. 23 (5): 1628–35. doi:10.1093/ndt/gfm813. PMID 18057066.